OpenAlex
PricingAboutJobs
Log inGet started
Work

Phase I clinical trial of recombinant human tumor necrosis factor

HTML

Year: 1987
Type: article
Study design: Clinical Trial
Source: Cancer Chemotherapy and Pharmacology
DOI: 10.1007/bf00253968
Authors: PatrickJ. Creaven, JohnE. Plager, Sherry Dupere, RobertP. Huben, Hiroshi Takita, Arnold Mittelman, April Proefrock
Institutions: Roswell Park Comprehensive Cancer Center, New York State Department of Health
Language: English

Topic: Immunotoxicology and immune responses
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: recombinant human tumor necrosis factor, pharmacokinetics, dose-limiting toxicity, hypotension, fever and chills, SGOT elevation, eosinophilia, plasma clearance, plasma half-life, intravenous infusion, cytokine therapy
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2000320798
FWCI: 3.219
Cites: 4
Cited by: 155
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security